Schonfeld Strategic Advisors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-954
| Closed | -$445K | – | 2404 |
|
|
2025
Q4 | $445K | Buy |
+954
| New | +$443K | ﹤0.01% | 1436 |
|
|
2025
Q3 | – | Sell |
-979
| Closed | -$375K | – | 2350 |
|
|
2025
Q2 | $375K | Sell |
979
-2,792
| -74% | -$1.01M | ﹤0.01% | 1632 |
|
|
2025
Q1 | $1.3M | Buy |
+3,771
| New | +$1.21M | 0.01% | 1169 |
|
|
2024
Q4 | – | Sell |
-872
| Closed | -$354K | – | 2161 |
|
|
2024
Q3 | $354K | Sell |
872
-11,690
| -93% | -$4.28M | ﹤0.01% | 1572 |
|
|
2024
Q2 | $4.04M | Sell |
12,562
-13,186
| -51% | -$4.28M | 0.03% | 624 |
|
|
2024
Q1 | $8.59M | Buy |
25,748
+19,005
| +282% | +$5.81M | 0.06% | 430 |
|
|
2023
Q4 | $1.83M | Sell |
6,743
-58,572
| -90% | -$14.5M | 0.01% | 829 |
|
|
2023
Q3 | $16.1M | Buy |
65,315
+61,184
| +1,481% | +$16.7M | 0.12% | 230 |
|
|
2023
Q2 | $1.25M | Buy |
4,131
+3,118
| +308% | +$867K | 0.01% | 907 |
|
|
2023
Q1 | $267K | Sell |
1,013
-28,128
| -97% | -$7.14M | ﹤0.01% | 1417 |
|
|
2022
Q4 | $6.99M | Sell |
29,141
-2,749
| -9% | -$616K | 0.06% | 392 |
|
|
2022
Q3 | $5.86M | Sell |
31,890
-63,503
| -67% | -$12.7M | 0.05% | 480 |
|
|
2022
Q2 | $16M | Buy |
95,393
+88,493
| +1,283% | +$19M | 0.16% | 176 |
|
|
2022
Q1 | $1.73M | Sell |
6,900
-3,027
| -30% | -$760K | 0.02% | 792 |
|
|
2021
Q4 | $2.55M | Buy |
+9,927
| New | +$2.43M | 0.02% | 641 |
|
|
2021
Q2 | – | Sell |
-10,250
| Closed | -$1.93M | – | 2086 |
|
|
2021
Q1 | $1.93M | Sell |
10,250
-122,261
| -92% | -$21.6M | 0.02% | 672 |
|
|
2020
Q4 | $21.8M | Buy |
132,511
+98,349
| +288% | +$14.4M | 0.29% | 70 |
|
|
2020
Q3 | $4.26M | Sell |
34,162
-10,126
| -23% | -$1.25M | 0.08% | 334 |
|
|
2020
Q2 | $4.3M | Buy |
44,288
+35,795
| +421% | +$3.72M | 0.11% | 259 |
|
|
2020
Q1 | $763K | Buy |
8,493
+3,558
| +72% | +$461K | 0.05% | 455 |
|
|
2019
Q4 | $730K | Sell |
4,935
-5,765
| -54% | -$774K | 0.02% | 603 |
|
|
2019
Q3 | $1.29M | Buy |
+10,700
| New | +$1.38M | 0.04% | 408 |
|
|
2018
Q3 | – | Sell |
-3,054
| Closed | -$313K | – | 893 |
|
|
2018
Q2 | $313K | Sell |
3,054
-6,164
| -67% | -$624K | 0.02% | 628 |
|
|
2018
Q1 | $894K | Buy |
+9,218
| New | +$894K | 0.07% | 347 |
|
|
2017
Q1 | – | Sell |
-4,175
| Closed | -$309K | – | 653 |
|
|
2016
Q4 | $309K | Buy |
+4,175
| New | +$313K | 0.04% | 421 |
|
|
2016
Q3 | – | Sell |
-3,306
| Closed | -$255K | – | 466 |
|
|
2016
Q2 | $255K | Buy |
+3,306
| New | +$261K | 0.06% | 341 |
|
Other funds holding HCA
VCM
VPM
Schonfeld Strategic Advisors's HCA Position: Q1 2026 in Review
Schonfeld Strategic Advisors sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 954 shares — an estimated $445K sold.
Schonfeld Strategic Advisors first reported a position in HCA in Q2 2016 and held it in 26 quarters. The position peaked at $21.8M in Q4 2020. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Schonfeld Strategic Advisors reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 954 HCA Healthcare shares in Q1 2026, an estimated $445K.
- Schonfeld Strategic Advisors first reported a position in HCA Healthcare in Q2 2016 and held it in 26 quarters.
- Schonfeld Strategic Advisors's HCA Healthcare position peaked at $21.8M in Q4 2020.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.